S
Shuki Mizutani
Researcher at Tokyo Medical and Dental University
Publications - 220
Citations - 7872
Shuki Mizutani is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: Leukemia & Hematopoietic stem cell transplantation. The author has an hindex of 44, co-authored 217 publications receiving 7300 citations.
Papers
More filters
Journal ArticleDOI
Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity
Yoshiyuki Minegishi,Masako Saito,Tomohiro Morio,Ken Watanabe,Kazunaga Agematsu,Shigeru Tsuchiya,Hidetoshi Takada,Toshiro Hara,Nobuaki Kawamura,Tadashi Ariga,Hideo Kaneko,Naomi Kondo,Ikuya Tsuge,Akihiro Yachie,Yukio Sakiyama,Tsutomu Iwata,Fumio Bessho,Tsutomu Oh-ishi,Kosuke Joh,Kohsuke Imai,Kazuhiro Kogawa,Miwa Shinohara,Mikiya Fujieda,Hiroshi Wakiguchi,Srdjan Pasic,Mario Abinun,Hans D. Ochs,Eleonore D. Renner,Eleonore D. Renner,Annette Jansson,Bernd H. Belohradsky,Ayse Metin,Norio Shimizu,Shuki Mizutani,Toshio Miyawaki,Shigeaki Nonoyama,Hajime Karasuyama +36 more
TL;DR: It is demonstrated that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially fromTyk2 function in mice.
Journal ArticleDOI
Clinical course of patients with WASP gene mutations
Kohsuke Imai,Tomohiro Morio,Yi Zhu,Yinzhu Jin,Sukeyuki Itoh,Michiko Kajiwara,Jun Ichi Yata,Shuki Mizutani,Hans D. Ochs,Shigeaki Nonoyama +9 more
TL;DR: It is demonstrated that WAS protein expression is a useful tool for predicting long-term prognosis for patients with WAS/XLT and hematopoietic stem cell transplantation should be considered, especially for WASP-negative patients, while the patients are young to improve prognosis.
Journal Article
Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.
F E Alexander,S L Patheal,Andrea Biondi,Silvia Regina Brandalise,Maria Elena Cabrera,Li Chong Chan,Z Chen,Giuseppe Cimino,J C Cordoba,L J Gu,Hany Hussein,Eiichi Ishii,Azza M. Kamel,S Labra,I Q Magalhães,Shuki Mizutani,Eleni Petridou,M P de Oliveira,P Yuen,Joseph L. Wiemels,Mel Greaves +20 more
TL;DR: The data suggest that specific chemical exposures of the fetus during pregnancy may cause MLL gene fusions, and the widespread use of dipyrone, Baygon, and other carbamate-based insecticides in certain settings is urgently required.
Journal ArticleDOI
Chk2 Activation Dependence on Nbs1 after DNA Damage
Giacomo Buscemi,Camilla Savio,Laura Zannini,Francesca Miccichè,Debora Masnada,Makoto Nakanishi,Hiroshi Tauchi,Kenshi Komatsu,Shuki Mizutani,Kum Kum Khanna,Phil Chen,Patrick Concannon,Luciana Chessa,Domenico Delia +13 more
TL;DR: It is shown that the ATM-dependent activation of Chk2 by γ- radiation requires Nbs1, the gene product involved in the Nijmegen breakage syndrome (NBS), a disorder that shares with AT a variety of phenotypic defects including chromosome fragility, radiosensitivity, and radioresistant DNA synthesis, and suggest that checkpoint defects in NBS cells may result from the inability to activate Chk1.
Journal ArticleDOI
Identification of a gene expression signature associated with pediatric AML prognosis
Tomohito Yagi,Akira Morimoto,Mariko Eguchi,Shigeyoshi Hibi,Masahiro Sako,Eiichi Ishii,Shuki Mizutani,Shinsaku Imashuku,Misao Ohki,Hitoshi Ichikawa +9 more
TL;DR: The results indicate the existence of prognosis-associated genes that are independent of cell lineage and cytogenetic abnormalities, and they can provide therapeutic direction for individual risk-adapted therapy for pediatric AML patients.